Canagliflozin is a C-glycosyl compound that functions as an inhibitor of sodium-glucose transport protein subtype 2. It is utilized as a hypoglycemic agent and is employed in pharmaceutical manufacturing for the management of type II diabetes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 928672-86-0
Canagliflozin
active pharmaceutical ingredient
Seladelpar lysine
active pharmaceutical ingredient
Elinzanetant
non-hormonal NK-1 and NK-3 receptor antagonist
Dotarem
MRI contrast agent
Guaifenesina
Expectorant active pharmaceutical ingredient
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
pharmaceutical intermediate
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), (1S)-
research compound
(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F